{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:02:37Z","timestamp":1792594957755,"version":"4.5.0"},"reference-count":22,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2014,2,1]]},"abstract":"<jats:p>Melasma is an acquired cutaneous disorder caused by an overproduction of melanin by the enzyme tyrosinase. Melasma remains a therapeutic challenge and no definitive standard therapy exists. Although hydroquinone (HQ) has emerged as the most common treatment, its popularity has recently waned because of concerns about its potential carcinogenicity and manufacturing challenges. The adverse effects of HQ range from the common irritant contact dermatitis to the less frequent exogenous ochronosis (EO). Previous reports suggest that the risk of leukoderma from HQ treatment is limited to individuals of African descent. Herein, we describe for the first time the development of depigmentation and paradoxical hyperpigmentation in 2 patients with Fitzpatrick skin type III\/IV after brief treatment of their melasma with the HQ-containing Nu-Derm and Reverse systems.<\/jats:p>","DOI":"10.1097\/01.der.0000438425.56740.8a","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T12:01:38Z","timestamp":1397649698000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":57,"title":["Hydroquinone-Induced Depigmentation: Case Report and Review of the Literature"],"prefix":"10.1177","volume":"25","author":[{"given":"Tiffany","family":"Jow","sequence":"first","affiliation":[{"name":"From the *Department of Dermatology, New Jersey Medical School, Newark, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil M.","family":"Hantash","sequence":"additional","affiliation":[{"name":"Elixir Institute of Regenerative Medicine, San Jose, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2014,2,1]]},"reference":[{"issue":"4","key":"e_1_3_1_2_2","doi-asserted-by":"crossref","DOI":"10.4103\/0019-5154.57602","article-title":"Topical treatment of melasma","volume":"54","author":"Bandyopadhyay D","year":"2009","unstructured":"Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol, 2009; 54 (4): \u2013.","journal-title":"Indian J Dermatol"},{"issue":"6","key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials","volume":"55","author":"Gupta AK","year":"2006","unstructured":"Gupta AK, , Gover MD, , Nouri K, et al. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol, 2006; 55 (6): 1048\u20131065.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5021\/ad.2010.22.4.373","article-title":"What should be considered in treatment of melasma","volume":"22","author":"Kang HY","year":"2010","unstructured":"Kang HY, , Ortonne JP. What should be considered in treatment of melasma. Ann Dermatol, 2010; 22 (4): 373\u2013378.","journal-title":"Ann Dermatol"},{"issue":"9","key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/jid.2009.124","article-title":"Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase","volume":"129","author":"Abu Ubeid A","year":"2009","unstructured":"Abu Ubeid A, , Zhao L, , Wang Y, et al. Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase. J Invest Dermatol, 2009; 129 (9): 2242\u20132249.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000154419.18653.2e"},{"issue":"6","key":"e_1_3_1_7_2","first-page":"1","article-title":"Topical agents used in the management of hyperpigmentation","volume":"9","author":"Halder RM","year":"2004","unstructured":"Halder RM, , Richards GM. Topical agents used in the management of hyperpigmentation. Skin Therapy Lett, 2004; 9 (6): 1\u20133.","journal-title":"Skin Therapy Lett"},{"issue":"5","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/09546630903341945","article-title":"Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?","volume":"21","author":"se TW","year":"2010","unstructured":"se TW. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?. J Dermatolog Treat, 2010; 21 (5): 272\u2013275.","journal-title":"J Dermatolog Treat"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF01867498","article-title":"Die hydrochinonvergiftung","volume":"183","author":"Oettel H.","year":"1936","unstructured":"Oettel H. Die hydrochinonvergiftung. Arch Exp Pathol Pharmacol, 1936; 183: 319\u2013362.","journal-title":"Arch Exp Pathol Pharmacol"},{"issue":"2","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1473-2165.2005.40202.x","article-title":"Hydroquinone and its analogues in dermatology\u2014a potential health risk","volume":"4","author":"Westerhof W","year":"2005","unstructured":"Westerhof W, , Kooyers TJ. Hydroquinone and its analogues in dermatology\u2014a potential health risk. J Cosmet Dermatol, 2005; 4 (2): 55\u201359.","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"e_1_3_1_11_2","first-page":"20","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis EC","year":"2010","unstructured":"Davis EC, , Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol, 2010; 3 (7): 20\u201331.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0536.1989.tb03126.x","article-title":"Confetti-like depigmentation from hydroquinone","volume":"20","author":"Markey AC","year":"1989","unstructured":"Markey AC, , Black AK, , Rycroft RJ. Confetti-like depigmentation from hydroquinone. Contact Dermatitis, 1989; 20 (2): 148\u2013149.","journal-title":"Contact Dermatitis"},{"issue":"5","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1600-0536.1981.tb04080.x","article-title":"Vitiligo and occupational exposure to hydroquinone from servicing self-photographing machines","volume":"7","author":"Kersey P","year":"1981","unstructured":"Kersey P, , Stevenson CJ. Vitiligo and occupational exposure to hydroquinone from servicing self-photographing machines. Contact Dermatitis, 1981; 7 (5): 285\u2013287.","journal-title":"Contact Dermatitis"},{"issue":"4","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0536.1982.tb04219.x","article-title":"Leukoderma from bleaching creams containing 2% hydroquinone","volume":"8","author":"Fisher AA","year":"1982","unstructured":"Fisher AA. Leukoderma from bleaching creams containing 2% hydroquinone. Contact Dermatitis, 1982; 8 (4): 272\u2013273.","journal-title":"Contact Dermatitis"},{"issue":"1","key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0190-9622(82)80023-6","article-title":"Can bleaching creams containing 2% hydroquinone produce leukoderma?","volume":"7","author":"Anonymous","year":"1982","unstructured":"Anonymous. Can bleaching creams containing 2% hydroquinone produce leukoderma?. J Am Acad Dermatol, 1982; 7 (1): 134\u2013135.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"e_1_3_1_16_2","first-page":"105","article-title":"Two cases of occupational leucoderma following contact with hydroquinone monomethyl ether","volume":"29","author":"Chivers CP","year":"1972","unstructured":"Chivers CP. Two cases of occupational leucoderma following contact with hydroquinone monomethyl ether. Br J Ind Med, 1972; 29 (1): 105\u2013107.","journal-title":"Br J Ind Med"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2010.08.010"},{"issue":"6","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archopht.1947.00900010831007","article-title":"Corneal and conjunctival pigmentation among workers engaged in manufacture of hydroquinone","volume":"38","author":"Anderson B","year":"1947","unstructured":"Anderson B. Corneal and conjunctival pigmentation among workers engaged in manufacture of hydroquinone. Arch Ophthal, 1947; 38 (6): 812\u2013826.","journal-title":"Arch Ophthal"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01670.x"},{"issue":"5","key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jaad.2007.02.020","article-title":"The safety of hydroquinone: a dermatologist\u2019s response to the 2006 Federal Register","volume":"57","author":"Levitt J","year":"2007","unstructured":"Levitt J. The safety of hydroquinone: a dermatologist\u2019s response to the 2006 Federal Register. J Am Acad Dermatol, 2007; 57 (5): 854\u2013872.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1600-0536.1980.tb05627.x","article-title":"Occupational depigmentation due to a hydroquinone-containing photographic developer","volume":"6","author":"Frenk E","year":"1980","unstructured":"Frenk E, , Loi-Zedda P. Occupational depigmentation due to a hydroquinone-containing photographic developer. Contact Dermatitis, 1980; 6 (3): 238\u2013239.","journal-title":"Contact Dermatitis"},{"issue":"6","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0536.1981.tb04082.x","article-title":"Hypopigmentation from UV resin additive","volume":"7","author":"Whittington CV","year":"1981","unstructured":"Whittington CV. Hypopigmentation from UV resin additive. Contact Dermatitis, 1981; 7 (6): 289\u2013292.","journal-title":"Contact Dermatitis"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2133.1975.tb05110.x","article-title":"Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams","volume":"93","author":"Findlay G","year":"1975","unstructured":"Findlay G, , Morrison J, , Simson I. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. British Journal of Dermatology, 1975; 93: 613\u2013622.","journal-title":"British Journal of Dermatology"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/01.DER.0000438425.56740.8a","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/01.DER.0000438425.56740.8a","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/01.DER.0000438425.56740.8a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:08:13Z","timestamp":1777399693000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/01.DER.0000438425.56740.8a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2,1]]}},"alternative-id":["10.1097\/01.DER.0000438425.56740.8a"],"URL":"https:\/\/doi.org\/10.1097\/01.der.0000438425.56740.8a","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,1]]}}}